Daphne S Bakker

16PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyAllergyMolecular targetsTumour immunologyDental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten

|Feb 05, 2025
Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment.

Celeste M Boesjes, Lian F van der Gang, Daphne S Bakker

|Dec 14, 2024
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels.

Coco Dekkers, Nicolaas Zuithoff, Daphne Bakker

|Oct 25, 2024
Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients.

Coco Dekkers, Hidde Smits, Dora Stölzl

|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.

Roselie Achten, Judith Thijs, Marlot van der Wal

|Dec 30, 2023
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation.

Celeste M Boesjes, Daphne S Bakker, Edward F Knol

Pageof 3

Frequent Collaborators

12 joint publications

Marjolein S de Bruin-Weller

8 joint publications

Judith Thijs

6 joint publications

Celeste M Boesjes

5 joint publications

Roselie E Achten